CME Group Inc. (CME) Market Cap & Valuation Ratios
CME Group Inc. (CME) has a market cap of $109.9B, a trailing P/E of 25.1 and a price-to-sales ratio of 15.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
CMECME Group Inc.Follow CME — free
—
Price chart with a free account
- Market cap
- 109.9B
- P/E TTM
- 25.1
- Dividend yield
- 1.6%
- 52-week
- —
- Next earnings
- 2 Feb, in 101 days
Peers
financial data & stock exchanges · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| CME | 110 | 25.1 | 4.14 | 16% | 1.6% | +9% |
| SPGI | 133 | 27.4 | 4.21 | 15% | — | +10% |
| ICE | 91 | 23.0 | 3.09 | 14% | 1.2% | +7% |
| MCO | 83 | 29.5 | 25.50 | 80% | 0.8% | +9% |
| NDAQ | 57 | 28.0 | 4.74 | 17% | 1.1% | +11% |
| MSCI | 44 | 32.6 | — | — | 1.3% | +12% |
| COIN | 43 | — | 3.32 | -8% | — | -10% |
| CBOE | 36 | 26.5 | 6.32 | 26% | 0.8% | +12% |
| TRU | 16 | 21.5 | 3.22 | 16% | 0.6% | +12% |
| FDS | 12 | 22.8 | 5.84 | 25% | 1.4% | +7% |
| MORN | 8.4 | 21.4 | 8.24 | 32% | 0.9% | +9% |
| Median of these 10 | 26.5 | 4.74 | 17% | 1.0% | +10% |
P/E 25.1 vs. a peer median of 26.5; P/B 4.14 vs. 4.74. CME's own P/E sits at the 44th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCOIN has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
CME Group Inc. — questions
- What is CME Group Inc.'s market cap?
- $109.9B.
- What is CME Group Inc.'s P/E ratio?
- 25.1 on trailing twelve-month earnings to 2026-09-30.
- What is CME Group Inc.'s price-to-sales ratio?
- 15.8.
Every figure on this page comes from CME Group Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.